What is WellDoc?
WellDoc operates at the intersection of technology and clinical care, providing a sophisticated digital health platform designed to manage chronic conditions such as diabetes, hypertension, and heart failure. By integrating real-time, actionable insights into the daily workflows of patients and providers, the company facilitates improved health outcomes and operational efficiency. Its market position is defined by its ability to bridge the gap between patient-generated data and clinical decision-making, effectively transforming the standard of care for individuals living with complex, long-term health challenges.
How much funding has WellDoc raised?
WellDoc has raised a total of $56.3M across 6 funding rounds:
Private Equity
$1M
Private Equity
$8.4M
Series A
$20M
Private Equity
$4.5M
Series B
$22M
Debt
$350K
Private Equity (2006): $1M, investors not publicly disclosed
Private Equity (2012): $8.4M, investors not publicly disclosed
Series A (2014): $20M supported by Merck Global Health Innovation Fund, Windham Venture Partners, and TCP Venture Capital
Private Equity (2014): $4.5M, investors not publicly disclosed
Series B (2015): $22M backed by Hudson River Capital Partners, Alexandria Venture Investments, Excel Venture Management, Adage Capital Management, and Samsung Ventures
Debt (2020): $350K with participation from PPP
Key Investors in WellDoc
Merck Global Health Innovation Fund
A corporate venture arm of the global healthcare leader Merck & Co., focusing on innovative solutions in medicines, vaccines, and digital health technologies.
Windham Venture Partners
A New York-based venture capital firm specializing in medical technology and digital health, known for maintaining close relationships with industry strategics and innovators.
TCP Venture Capital
An early-stage venture firm based in Baltimore that partners with entrepreneurs to build high-growth technology companies, specifically targeting capital-efficient business models.
What's next for WellDoc?
Following this major strategic investment, WellDoc is positioned to scale its multi-condition support infrastructure to meet the growing demand for remote patient monitoring and digital therapeutics. The company is expected to leverage this capital to enhance its data analytics capabilities and expand its footprint within enterprise healthcare systems. By focusing on scalable, evidence-based interventions, WellDoc aims to further solidify its role as a critical partner for health systems seeking to optimize chronic disease management and reduce the total cost of care.
See full WellDoc company page
